20. November 2009 11:45
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
[More]
20. November 2009 09:23
Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
[More]
20. November 2009 07:45
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.
[More]
25d5bf3a-1a13-4ddf-befb-b2fa1aaa7721|0|.0
Posted in: Device / Technology News | Pharmaceutical News
Tags: Allergy, Anthrax, Beclomethasone, Biotechnology, Cancer, Cell, Corticosteroid, Drug Delivery, Endometriosis, Prostate Cancer, Vaccine
20. November 2009 05:32
Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level.
[More]
20. November 2009 04:23
U.S. Health and Human Services Secretary Kathleen Sebelius is to be commended for publicly stating the government panel opposing mammograms is "an outside independent panel of doctors and scientists who ... do not set federal policy and ... don't determine what services are covered by the federal government."
[More]
19. November 2009 10:32
Everyone has been trying to come up with a good nickname for the 10 years we're concluding next month. Terror Era really sounds like too much of a downer. How about the Decade of Medical Backtracking? Somewhere between the reports that Pap smears and tests for prostate cancer aren't all they were cracked up to be and the news that a high fiber diet doesn't do anything to prevent cancer, the health establishment began looking decidedly nonomniscient. Then this week, a federal task force reported that most women don't need annual mammograms (Gail Collins, 11/18).
[More]
19. November 2009 07:27
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
[More]
19. November 2009 01:49
iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a strategic partnership with the AdMeTech Foundation, a non-profit organization with a mission to end prostate cancer as a patient care crisis and socio-economic problem.
[More]
30aab460-b81f-4f5f-b57f-20a4cfca940d|0|.0
Posted in: Business / Finance | Device / Technology News | Medical Condition News
Tags: Biopsy, Breast Cancer, Cancer, Education, Lung Cancer, Mammography, Prostate Cancer, Radiation Therapy, Spectroscopy, Telemedicine, Ultrasound
19. November 2009 01:37
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
[More]
93413953-874e-4748-8590-f191a2cb10c2|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Anesthesiology, Angiogenesis, Brain, Cancer, Cell, Cell Proliferation, Constipation, Life Expectancy, Lung Cancer, Metastasis, Morphine, Non-Small Cell Lung Cancer, Prostate Cancer, Small Cell Lung Cancer
18. November 2009 08:40
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
[More]
7105e9d6-13ab-4fd4-afa9-3e55eccba03a|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Acute Lymphoblastic Leukemia, Apoptosis, Breast Cancer, Cancer, Cell, Chronic Myeloid Leukemia, Colon Cancer, Erlotinib, Gleevec, Hospital, Leukemia, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Myeloid Leukemia, Non-Small Cell Lung Cancer, Oncology, Paclitaxel, Pancreatic Cancer, Prostate Cancer, Small Cell Lung Cancer, Sunitinib, Tarceva, Xenograft
18. November 2009 05:12
IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease.
[More]
8ce0198e-2d36-495d-8092-427c2d4d0ef7|1|5.0
Posted in: Device / Technology News
Tags: Antibody, Antiretroviral, Biotechnology, Breast Cancer, Cancer, Cardiovascular Disease, Dengue Fever, E. coli, Epstein-Barr Virus, Evolution, H1N1, Hepatitis C, Hospital, Influenza, Lung Cancer, Mammography, Microfluidics, Pregnancy, Prostate Cancer, Virus
18. November 2009 04:36
Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
[More]
ebd940d6-5ee0-4981-9f9c-9cbd4c54ac6a|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Bone, Bone Marrow, Cancer, Chemotherapy, Colorectal Cancer, Fluorouracil, Neuropathy, Neutropenia, Oncology, Oxaliplatin, Prostate Cancer, Thrombocytopenia
18. November 2009 04:30
NeoPharm, Inc. today announced the results of a Phase I clinical trial of Liposome Encapsulated Docetaxel (LE-DT) an active component of Taxotere® at a joint International Conference of the American Association for Cancer Research (AACR), the National Cancer Institute (NCI) and the European Organization for Research and Treatment of Cancer (EORTC) being held in Boston, MA.
[More]
fb71fcf5-7a8a-4a34-a06b-4ea9eafc39f8|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Alopecia, Antihistamine, Back Pain, Cancer, Diarrhea, Docetaxel, Edema, Liposome, Nausea, Neuropathy, Neutropenia, Peripheral Neuropathy, Prostate Cancer, Taxotere
18. November 2009 01:30
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
[More]
17. November 2009 08:41
Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.
[More] 
Subscribe